Skip to Main Content

Advertisement intended for health care professionals

Skip Nav Destination

Stephen M. Ansell, MD, PhD: Nivolumab Moves to Hematology

December 30, 2021

Dr. Ansell, a speaker in the Special Education Session on Newly Approved Drugs, discusses the growing role of nivolumab in hematologic malignancies.

Advertisement intended for health care professionals

Connect with us:

CURRENT ISSUE
November 2024

Advertisement intended for health care professionals

Close Modal

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals